For the most sensitive or sensitive locations (C, AuI, and/or M@AuI), the EMFs for the “antibody–NSE–antibody” dimer were stronger than those for the “antibody–CEA–antibody” dimer, which was confirmed by experimental data from SERS detection of the cancer biomarkers CEA and NSE. The gene discussed is CEACAM5; the disease is cancer.